Nuclear Medicine Market to Record 19.5% CAGR from 2023 to 2030; GE Healthcare Expands Portfolio with Acquisition of Zionexa and FDA Approval of Cerianna for Metastatic Breast Cancer
Request for Customization
- Get in Touch with Us
-
-
Healthcare Clients
